Naringenin Decreases Invasiveness and Metastasis by Inhibiting TGF-β-Induced Epithelial to Mesenchymal Transition in Pancreatic Cancer Cells

A single-molecule study of the inhibition effect of Naringenin on transforming growth factor-β ligand–receptor binding

(2011) Yong Yang et al.   CHEMICAL COMMUNICATIONS

Ablation of Smurf2 reveals an inhibition in TGF-β signalling through multiple mono-ubiquitination of Smad3

(2011) Liu-Ya Tang et al.   EMBO JOURNAL

Effects of Flavonoids on Matrix Metalloproteinase-13 Expression of Interleukin-1β–Treated Articular Chondrocytes and Their Cellular Mechanisms: Inhibition of c-Fos/AP-1 and JAK/STAT Signaling Pathways

(2011) Hyun Lim et al.   JOURNAL OF PHARMACOLOGICAL SCIENCES

Naringenin reduces lung metastasis in a breast cancer resection model

(2011) Lei Qin et al.   Protein & Cell

Retracted: Restoring sensitivity to oxaliplatin by a novel approach in gemcitabine-resistant pancreatic cancer cellsin vitroandin vivo

(2010) Sanjeev Banerjee et al.   INTERNATIONAL JOURNAL OF CANCER

Transforming growth factor-β induces epithelial to mesenchymal transition and suppresses the proliferation and transdifferentiation of cultured human pancreatic duct cells

(2010) Jeong-Ah Shin et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Pancreatic cancer: understanding and overcoming chemoresistance

(2010) Zhiwei Wang et al.   Nature Reviews Gastroenterology & Hepatology

Phenolic Compounds as Selective Antineoplasic Agents against Multidrug-resistant Human Cancer Cells

(2010) Noélia Duarte et al.   PLANTA MEDICA

Naringenin: A Potential Immunomodulator for Inhibiting Lung Fibrosis and Metastasis

(2009) G. Du et al.   CANCER RESEARCH

Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer

(2009) T. Arumugam et al.   CANCER RESEARCH

Epithelial-Mesenchymal Transitions in Development and Disease

(2009) Jean Paul Thiery et al.   CELL

Effects of low dose quercetin: Cancer cell-specific inhibition of cell cycle progression

(2008) Jae-Hoon Jeong et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Naringenin Enhances the Anti-Tumor Effect of Doxorubicin Through Selectively Inhibiting the Activity of Multidrug Resistance-Associated Proteins but not P-glycoprotein

(2008) Fa Yun Zhang et al.   PHARMACEUTICAL RESEARCH